Rockefeller Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.1M | Buy |
41,556
+116
| +0.3% | +$43K | 0.02% | 555 |
|
|
2026
Q1 | $12.1M | Buy |
41,440
+893
| +2% | +$293K | 0.02% | 607 |
|
|
2025
Q4 | $14.2M | Sell |
40,547
-8,288
| -17% | -$2.8M | 0.03% | 532 |
|
|
2025
Q3 | $15.8M | Buy |
48,835
+280
| +0.6% | +$87.1K | 0.03% | 490 |
|
|
2025
Q2 | $18.9M | Buy |
48,555
+1,676
| +4% | +$674K | 0.04% | 406 |
|
|
2025
Q1 | $20.4M | Buy |
46,879
+1,621
| +4% | +$651K | 0.05% | 359 |
|
|
2024
Q4 | $16.7M | Sell |
45,258
-5,145
| -10% | -$2.15M | 0.04% | 393 |
|
|
2024
Q3 | $26.2M | Sell |
50,403
-418
| -0.8% | -$223K | 0.07% | 276 |
|
|
2024
Q2 | $27.5M | Sell |
50,821
-2,000
| -4% | -$1.06M | 0.08% | 241 |
|
|
2024
Q1 | $27.4M | Buy |
52,821
+8,336
| +19% | +$4.15M | 0.08% | 245 |
|
|
2023
Q4 | $21M | Buy |
44,485
+26
| +0.1% | +$12K | 0.07% | 283 |
|
|
2023
Q3 | $19.4M | Sell |
44,459
-1,659
| -4% | -$752K | 0.07% | 268 |
|
|
2023
Q2 | $20.5M | Buy |
46,118
+4,122
| +10% | +$1.9M | 0.08% | 259 |
|
|
2023
Q1 | $19.3M | Sell |
41,996
-627
| -1% | -$298K | 0.08% | 269 |
|
|
2022
Q4 | $21.9M | Sell |
42,623
-723
| -2% | -$367K | 0.11% | 209 |
|
|
2022
Q3 | $19.7M | Sell |
43,346
-835
| -2% | -$400K | 0.1% | 216 |
|
|
2022
Q2 | $21.3M | Sell |
44,181
-1,385
| -3% | -$685K | 0.11% | 191 |
|
|
2022
Q1 | $22.4M | Buy |
45,566
+6,556
| +17% | +$3M | 0.11% | 207 |
|
|
2021
Q4 | $18.1M | Sell |
39,010
-151
| -0.4% | -$63.5K | 0.08% | 235 |
|
|
2021
Q3 | $14.6M | Sell |
39,161
-174
| -0.4% | -$66.1K | 0.08% | 259 |
|
|
2021
Q2 | $15M | Buy |
39,335
+1,324
| +3% | +$506K | 0.08% | 241 |
|
|
2021
Q1 | $13.6M | Buy |
38,011
+943
| +3% | +$303K | 0.09% | 215 |
|
|
2020
Q4 | $11.9M | Buy |
37,068
+7,827
| +27% | +$2.4M | 0.09% | 212 |
|
|
2020
Q3 | $7.85M | Buy |
29,241
+4,822
| +20% | +$1.3M | 0.07% | 218 |
|
|
2020
Q2 | $6.42M | Sell |
24,419
-1,463
| -6% | -$390K | 0.07% | 219 |
|
|
2020
Q1 | $5.88M | Buy |
25,882
+528
| +2% | +$144K | 0.08% | 205 |
|
|
2019
Q4 | $7.66M | Buy |
25,354
+25
| +0.1% | +$6.88K | 0.1% | 173 |
|
|
2019
Q3 | $6.08M | Sell |
25,329
-6,090
| -19% | -$1.67M | 0.08% | 173 |
|
|
2019
Q2 | $8.87M | Sell |
31,419
-3,588
| -10% | -$980K | 0.12% | 126 |
|
|
2019
Q1 | $10M | Buy |
35,007
+4,333
| +14% | +$1.25M | 0.14% | 118 |
|
|
2018
Q4 | $8.05M | Buy |
30,674
+225
| +0.7% | +$61.9K | 0.14% | 117 |
|
|
2018
Q3 | $8.35M | Hold |
30,449
| – | – | 0.13% | 115 |
|
|
2018
Q2 | $7.25M | Hold |
30,449
| – | – | 0.12% | 115 |
|
|
2018
Q1 | $6.69M | Buy |
+30,449
| New | +$7.15M | 0.11% | 120 |
|
Other funds holding ELV
Rockefeller Capital Management's ELV Position: Q2 2026 in Review
Rockefeller Capital Management increased its Elevance Health (ELV) stake by 0.28% in Q2 2026, buying an estimated $43K and bringing the position to 41,556 shares worth $16.1M. The position accounts for 0.02% of the portfolio, ranked #555.
Rockefeller Capital Management first reported a position in ELV in Q1 2018 and has held it in 34 quarters since. The position peaked at $27.5M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Rockefeller Capital Management held 41,556 shares of Elevance Health worth $16.1M as of Q2 2026.
- Rockefeller Capital Management bought 116 Elevance Health shares in Q2 2026, an estimated $43K.
- Elevance Health made up 0.02% of Rockefeller Capital Management's portfolio in Q2 2026, its #555 holding.
- Rockefeller Capital Management first reported a position in Elevance Health in Q1 2018 and has held it in 34 quarters since.
- Rockefeller Capital Management's Elevance Health position peaked at $27.5M in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.